Zaneta Phean CIS 1055 Section 008 October 1, 2012 Pfizer Zaneta Phean CIS 1055 Section 008 October 1, 2012

About pfizer committed to applying science and our global resources to improve health and well-being at every stage of life provide access to safe, effective and affordable medicines and related health care services to the people who need them leading portfolio of products and medicines that support wellness and prevention treatment and cures for diseases across a broad range of therapeutic areas industry-leading pipeline of promising new products that have the potential to challenge some of the most feared diseases of our time, like Alzheimer's disease and cancer managed care organizations to world governments and non-governmental organizations goal is to ensure that people everywhere have access to innovative treatments and quality health care Zaneta Phean Section 008

timeline Zaneta Phean Section 008 1849 – 1899 In 1849, cousins Charles Pfizer and Charles Erhart founded Charles Pfizer & Company in a red brick building in Brooklyn, NY. 1900 – 1950 The new century brought prosperity to Pfizer. The pioneering of the mass production of citric acid from sugar through mold fermentation fueled growth for years. 1951 – 1999 The second half of the 1900´s saw intense pharmaceutical research and great successes for Pfizer. 2000 – Present Pfizer increases its global presence through the acquisitions of Warner-Lambert and Pharmacia. Additionally, through strategic partnerships and acquisitions of diversified businesses, such as Wyeth, Pfizer solidifies its place as one of the most diversified companies in the global health care industry. Pfizer continues to focus on applying science and the company's global resources to improve health and well-being at every stage of life. Zaneta Phean Section 008

Cofounders Charles Pfizer Charles Erhart click arrow to meet the present Executive Leadership Team Zaneta Phean Section 008

Executive Leadership Team Ian Read Chairman of the Board and Chief Executive Officer Mikael Dolsten President, Worldwide Research & Development Freda C. Lewis-Hall Executive Vice President, Chief Medical Officer Geno Germano President and General Manager, Specialty Care and Oncology Laurie Olson Executive Vice President, Strategy, Portfolio Management and Global Commercial Operations Sally Susman Executive Vice President, Policy, External Affairs and Communications Chuck Hill Executive Vice President, Worldwide Human Resources Kristin Peck Executive Vice President, Worldwide Business Development and Innovation John Young President and General Manager, Primary Care Hugh Donnelly Vice President, Corporate Audi Doug Lankler Executive Vice President, Chief Compliance & Risk Officer Amy Schulman Executive Vice President and General Counsel; Business Unit Lead, Consumer Healthcare; President and General Manager, Nutrition Olivier Brandicourt President and General Manager, Emerging Markets and Established Products Frank D'Amelio Executive Vice President, Chief Financial Officer and Business Operations Zaneta Phean Section 008 click arrow to go back to previous page

Products Pfizer product information is intended only for residents of the United States Pfizer medicines help to treat and prevent a range of conditions from the most common to the most challenging for people around the world Here is a list of a few Pfizer products people may be familiar with: Advil Brands Centrum Brands Chapstick Neosporin Robitussin Zaneta Phean Section 008

Competitors Merck & Co. Inc. Novartis AG Sanofi Drug Manufacturers - Major Zaneta Phean Section 008

Recent News September 21, 2012  — Pfizer Invites Public To View And Listen To Webcast Of October 30 Conference Call With Analysts   September 21, 2012  — ELIQUIS® (apixaban) Receives CHMP Positive Opinion For The Prevention Of Stroke And Systemic Embolism In Patients With Nonvalvular Atrial Fibrillation September 17, 2012  — Pfizer Announces Data For Investigational Compound Tofacitinib In Rheumatoid Arthritis To Be Presented At The American College Of Rheumatology 2012 Annual Meeting September 17, 2012  — Pfizer To Present New Data in Lung And Kidney Cancers at The European Society For Medical Oncology 2012 Congress September 13, 2012  — Pfizer and Waste Management Launch Online Pharmaceutical Disposal Guide September 13, 2012  — Pfizer Invites Public to View and Listen to Webcast of Pfizer Presentation at Healthcare Conference Zaneta Phean Section 008

Zaneta Phean Section 008

For More Information Call Us Customer Service and Product Inquiries:  1-800-TRY-FIRST (1-800-879-3477)  Monday through Friday 8:00 a.m. to 8:00 p.m. EST  Corporate Office:  1-212-733-2323  235 East 42nd Street  New York, NY 10017  Frequently asked questions Send Email Zaneta Phean Section 008